Lauren White

Insider Reports History

Entity
Individual
Location
C4 Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown, MA
Signature
/s/ Joseph J. Kenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lauren White:

Stock Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Financial Officer Common Stock 32.7K $213K $6.52 Aug 30, 2023 Direct
C4 Therapeutics, Inc. Chief Financial Officer Performance Restricted Stock Units 16.5K $105K $6.36 Aug 30, 2023 Direct
ImmunoGen, Inc. SVP, CFO AND PFO Restricted Stock Unit 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. SVP, CFO AND PFO Stock Option (Right to Buy) 0 $0 $4.56 Feb 12, 2024 Direct

Insider Reports Filed by Lauren White

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMGN ImmunoGen, Inc. Feb 12, 2024 3 $0 4 Feb 12, 2024 SVP, CFO AND PFO
IMGN ImmunoGen, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 SVP, CFO AND PFO
IMGN ImmunoGen, Inc. Sep 18, 2023 2 $0 4 Sep 19, 2023 SVP, CFO AND PFO
IMGN ImmunoGen, Inc. Sep 18, 2023 0 $0 3 Sep 19, 2023 SVP, CFO and PFO
CCCC C4 Therapeutics, Inc. Aug 30, 2023 3 -$1.94K 4 Aug 31, 2023 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Feb 13, 2023 2 $0 4 Feb 15, 2023 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Jan 30, 2023 3 -$10.1K 4 Feb 1, 2023 Chief Financial Officer
CCCC C4 Therapeutics, Inc. May 26, 2022 1 -$7.73K 4/A Jun 14, 2022 Chief Financial Officer
CCCC C4 Therapeutics, Inc. May 25, 2022 2 $0 4 May 27, 2022 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Feb 14, 2022 2 $0 4 Feb 16, 2022 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Jun 21, 2021 1 $0 4 Jun 21, 2021 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Jun 21, 2021 0 $0 3 Jun 21, 2021 Chief Financial Officer